| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 78,7 k € | +15.9% | 68,0 k € | -9.0% | 74,7 k € | +268.1% | 20,3 k € | -78.0% | 92,1 k € | -54.1% | 200,5 k € | +28.1% | 156,5 k € | +2.8% | 152,2 k € | -11.3% | 171,6 k € | +147.0% | 69,5 k € | |
| EBITDA | 75,4 k € | +15.8% | 65,1 k € | -6.5% | 69,7 k € | +295.4% | 17,6 k € | -55.7% | 39,7 k € | -69.0% | 128,3 k € | +57.1% | 81,6 k € | -33.5% | 122,7 k € | -12.2% | 139,8 k € | +107.3% | 67,4 k € | |
| Operating profit | 32,9 k € | -30.0% | 47,0 k € | +47.5% | 31,8 k € | +265.5% | -19,2 k € | -178.0% | -6,9 k € | -106.4% | 108,5 k € | +105.7% | 52,8 k € | -43.2% | 92,9 k € | -16.4% | 111,1 k € | +158.9% | 42,9 k € | |
| Profit/loss | 23,0 k € | -37.6% | 36,9 k € | +53.7% | 24,0 k € | +194.9% | -25,3 k € | -87.7% | -13,5 k € | -116.7% | 80,5 k € | +120.1% | 36,6 k € | -36.5% | 57,6 k € | -17.2% | 69,6 k € | +168.0% | 26,0 k € | |
| Equity | 188,2 k € | +13.9% | 165,2 k € | 0.0% | 165,2 k € | +17.0% | 141,2 k € | -49.4% | 278,9 k € | -4.6% | 292,4 k € | +38.0% | 211,9 k € | +20.3% | 176,1 k € | +48.6% | 118,5 k € | +142.2% | 48,9 k € | |
| Total assets | 886,8 k € | +139.7% | 370,0 k € | +1.5% | 364,7 k € | +3.0% | 354,1 k € | -32.6% | 525,2 k € | -10.2% | 585,1 k € | +9.1% | 536,1 k € | -0.7% | 540,2 k € | +7.1% | 504,5 k € | +29.7% | 388,9 k € | |
| Cash | 46,9 k € | -50.0% | 93,8 k € | +1.7% | 92,2 k € | +21.7% | 75,8 k € | — | — | 200,2 k € | -7.5% | 216,4 k € | +53.0% | 141,4 k € | +13.1% | 125,1 k € | ||||
| Debts | 696,5 k € | +243.6% | 202,7 k € | +1.6% | 199,5 k € | -6.3% | 212,9 k € | -13.6% | 246,3 k € | -15.9% | 292,7 k € | -9.7% | 324,3 k € | -9.9% | 359,7 k € | -0.5% | 361,5 k € | +6.4% | 340,0 k € | |
Private company with limited liability · Drogenbos · incorporated on 16/10/2012
Private company with limited liability profitable and well capitalised. Cash position declining (-50.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CARACAL INVEST is a Private company with limited liability incorporated in 2012. Its main activity is: Translation and interpretation activities. Its registered office is in Drogenbos.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette